Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002014607 | SCV002233412 | uncertain significance | MHC class I deficiency | 2022-10-19 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with TAP1-related conditions. This variant is present in population databases (rs747716612, gnomAD 0.01%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 751 of the TAP1 protein (p.Arg751Trp). ClinVar contains an entry for this variant (Variation ID: 1449798). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). |
Ambry Genetics | RCV004681354 | SCV005167599 | uncertain significance | Inborn genetic diseases | 2024-05-16 | criteria provided, single submitter | clinical testing | The c.2251C>T (p.R751W) alteration is located in exon 11 (coding exon 11) of the TAP1 gene. This alteration results from a C to T substitution at nucleotide position 2251, causing the arginine (R) at amino acid position 751 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |